AGIO — Agios Pharmaceuticals, Inc. stock price, charts and financials

QT37Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
31.60
+1.06+3.47%
OverviewShort InterestFilings
AGIOQT37Agios Pharmaceuticals, Inc.·NASDAQ
31.60+3.47%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 30, 20268-KCurrent report
Jul 30, 202610-QQuarterly report
Jul 10, 20264Statement of changes in beneficial ownership
Jul 02, 2026SC 13GBeneficial ownership statement (passive)
Jul 02, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 18, 2026S-8Registration of employee benefit securities
Jun 18, 20268-KCurrent report
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
#1 / 25 of 404
Page
▼
/ 17